openPR Logo
Press release

Liver Fibrosis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Inventiva Pharma, Galmed, Clovis Oncology, Novartis, Hepion, Zedira, Pfizer, HEC Pharm, Genoscience

11-29-2023 07:41 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Liver Fibrosis Pipeline Analysis (2023) Covering Clinical

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 30+ pipeline drugs in the Liver Fibrosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Liver Fibrosis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Liver Fibrosis Therapeutics Market.

The report provides a detailed description of the Liver Fibrosis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Liver Fibrosis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/liver-fibrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Liver Fibrosis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Liver Fibrosis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Liver Fibrosis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Liver Fibrosis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Liver Fibrosis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Liver Fibrosis Therapeutics Domain @
https://www.delveinsight.com/report-store/liver-fibrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Liver Fibrosis Therapeutics Analysis
There are approx. 20+ key companies developing therapies for Liver Fibrosis. Currently, Inventiva Pharma is leading the therapeutics market with its Liver Fibrosis drug candidates in the most advanced stage of clinical development.

Liver Fibrosis Companies in the Therapeutics Market Include:
• Inventiva Pharma
• Galmed Pharmaceuticals
• Clovis Oncology
• Novartis
• Hepion Pharmaceuticals, Inc.
• Kowa Pharmaceutical
• Zedira GmbH
• Pfizer
• Beijing Continent Pharmaceutical Co, Ltd.
• Zydus Therapeutics Inc.
• TaiwanJ Pharmaceuticals Co., Ltd
• HEC Pharm
• Genoscience
• Ark Biosciences
And Many More

Emerging and Marketed Liver Fibrosis Therapies Covered in the Report Include:
• Lanifibranor: Inventiva Pharma
• Aramchol meglumine: Galmed Pharmaceuticals
• FAP-2286: Clovis Oncology
• Lanifibranor: Inventiva Pharma
• Aramchol: Galmed Research and Development
And Many Others

Get an in-depth Assessment of the Emerging Therapies and Liver Fibrosis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/liver-fibrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Liver Fibrosis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Liver Fibrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Liver Fibrosis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/liver-fibrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Liver Fibrosis Current Treatment Patterns
4. Liver Fibrosis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Liver Fibrosis Late-Stage Products (Phase-III)
7. Liver Fibrosis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Liver Fibrosis Discontinued Products
13. Liver Fibrosis Product Profiles
14. Liver Fibrosis Companies
15. Liver Fibrosis Drugs
16. Dormant and Discontinued Products
17. Liver Fibrosis Unmet Needs
18. Liver Fibrosis Future Perspectives
19. Liver Fibrosis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/liver-fibrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Functional Electrical Stimulation (FES) Devices Market
https://www.delveinsight.com/report-store/functional-electrical-stimulation-fes-devices-market

Hypoactive Sexual Desire Disorder Market
https://www.delveinsight.com/report-store/hypoactive-sexual-desire-disorder-hsdd-market

Complicated Intra-Abdominal Infections Market
https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market

Malignant Pleural Mesothelioma (MPM) Market
https://www.delveinsight.com/report-store/malignant-pleural-mesothelioma-market

Mitochondrial Myopathies Market
https://www.delveinsight.com/report-store/mitochondrial-myopathies-market

Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market

Mayus Kinase (jak) Inhibitors Market
https://www.delveinsight.com/report-store/mayus-kinase-inhibitors-market

Acute Heart Failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market

Bacterial Vaginosis Market
https://www.delveinsight.com/report-store/bacterial-vaginosis-market

Hyperphosphatemia Market
https://www.delveinsight.com/report-store/hyperphosphatemia-market

Pleural Effusion Market
https://www.delveinsight.com/report-store/pleural-effusion-market

Epidermolysis Bullosa Market
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market

Gestational Diabetes Market
https://www.delveinsight.com/report-store/gestational-diabetes-market

Intratumoral Cancer Therapies Market
https://www.delveinsight.com/report-store/intratumoral-cancer-therapies-market

Wasting Syndrome Market
https://www.delveinsight.com/report-store/wasting-syndrome-market

Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market

Vagus Nerve Stimulator (VNS) Global Market
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market

Abetalipoproteinemia Market
https://www.delveinsight.com/report-store/abetalipoproteinemia-market

Myelofibrosis (MF) Market
https://www.delveinsight.com/report-store/myelofibrosis-mf-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Homozygous Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market

Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market

West Nile Encephalitis Market
https://www.delveinsight.com/report-store/west-nile-encephalitis-market

Gonorrhea Market
https://www.delveinsight.com/report-store/gonorrhea-market

Polymyositis Market
https://www.delveinsight.com/report-store/polymyositis-market

Subarachnoid Hemorrhage Market
https://www.delveinsight.com/report-store/subarachnoid-hemorrhage-market

Acute Pancreatitis Market
https://www.delveinsight.com/report-store/acute-pancreatitis-market

Acute Respiratory Distress Syndrome (ARDS) Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market

PARP Inhibitors Market
https://www.delveinsight.com/report-store/parp-inhibitors-competitive-landscape-pipeline-and-market-analysis

Bacterial Conjunctivitis Market
https://www.delveinsight.com/report-store/bacterial-conjunctivitis-market

Desmoplastic Small Round Cell Tumors (DSRCTS) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market

Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market

Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market

Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market

PCSK9 Inhibitors Market
https://www.delveinsight.com/report-store/pcsk9-inhibitors-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Dravet Syndrome Market
https://www.delveinsight.com/report-store/dravet-syndrome-market

Genital Warts Market
https://www.delveinsight.com/report-store/genital-warts-condyloma-acuminatum-market

Orthopedic Trauma Devices Market
https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market

Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market

Erythema Market
https://www.delveinsight.com/report-store/erythema-market

Primary Open Angle Glaucoma (POAG) Market
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market

Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market
https://www.delveinsight.com/report-store/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market

Traumatic Brain Injury Assessment Devices Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-assessment-management-devices-market

Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market

Hormone Sensitive Advanced Prostate Cancer Market
https://www.delveinsight.com/report-store/hormone-sensitive-advanced-prostate-cancer-market

Neuromodulation Devices Global Market
https://www.delveinsight.com/report-store/neuromodulation-devices-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Fibrosis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Inventiva Pharma, Galmed, Clovis Oncology, Novartis, Hepion, Zedira, Pfizer, HEC Pharm, Genoscience here

News-ID: 3309404 • Views:

More Releases from DelveInsight Business Research LLP

Sapablursen Market Size and Share Across 7MM and Competitive Landscape by DelveInsight | Key Players - Ionis Pharmaceuticals
Sapablursen Market Size and Share Across 7MM and Competitive Landscape by DelveI …
DelveInsight has released a comprehensive report titled "Sapablursen Market Forecast" offering a thorough examination and predictive insights into the Sapablursen market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The extensive report offers a thorough examination of the market potential and market share of Sapablursen in the therapeutics landscape for Polycythemia Vera across the 7MM,
Sapablursen Market Size and Share Analysis Across 7MM and Competitive Landscape by DelveInsight | Key Players - Ionis Pharmaceuticals
Sapablursen Market Size and Share Analysis Across 7MM and Competitive Landscape …
DelveInsight has released a comprehensive report titled "Sapablursen Market Forecast" offering a thorough examination and predictive insights into the Sapablursen market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The extensive report offers a thorough examination of the market potential and market share of Sapablursen in the therapeutics landscape for Polycythemia Vera across the 7MM,
Complicated Urinary Tract Infections (cUTIs) Market Poised for Extraordinary Growth During the Forecast Period (2023-32), Asserts DelveInsight | Allecra Therapeutics (EXBLIFEP (cefepime/enmetazobactam)), Iterum, Venatorx, Nabriva, Wockhardt, MerLion
Complicated Urinary Tract Infections (cUTIs) Market Poised for Extraordinary Gro …
The Complicated Urinary Tract Infections (cUTIs) market is dynamically evolving with the development of novel antimicrobial agents, increased focus on antibiotic stewardship, and advancements in diagnostic technologies, offering the potential for more targeted and effective treatment options. Growing awareness of antibiotic resistance and the demand for alternative therapies are driving innovation and shaping the landscape of cUTI management, fostering improved patient outcomes. DelveInsight's "Complicated Urinary Tract Infections (cUTIs) Market Insights, Epidemiology,
Multiple Sclerosis Market Forecasts by DelveInsight Signal Groundbreaking Growth by 2032 | TG Therapeutics (BRIUMVI/ ublituximab-xiiy), Immunic, ANOKION, Osmotica Pharma, Alkermes, Biogen, Merck Healthcare, Clene Nanomedicine, Atara Biotherapeutics
Multiple Sclerosis Market Forecasts by DelveInsight Signal Groundbreaking Growth …
The Multiple Sclerosis (MS) market is experiencing significant evolution with the introduction of innovative disease-modifying therapies, advancements in precision medicine approaches, and increasing emphasis on personalized treatment strategies, promising improved management and outcomes for patients. Ongoing research efforts and the expanding understanding of the underlying mechanisms of Multiple Sclerosis are driving innovation and shaping the landscape, ushering in a new era of care for individuals affected by this complex neurological

All 5 Releases


More Releases for Liver

Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Im …
Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Main Benefits - Helps Protect The Liver From Harmful Toxins Side Effects - No Major Side Effects Reported Price - $39.97/bottle Availability - Only Official website ▻Official Website - https://bit.ly/3uB8LFO Bridport Health Reviews - Is it a 100% natural liver cleansing formula? Are the 's ingredients 100% natural & safe? Clinically proven? Read the ingredients & benefits before buying. Price
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver
Global Fatty Liver Disease Drugs Market : Global Fatty Liver Disease Drugs Marke …
Research By Markets adds "Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Countryc - By ALD Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH)" to its online repository. More information: https://www.researchbymarkets.com/report/global-fatty-liver-disease-drugs-market-by-type-ald-nafld-by-stages-of-ald-and-nafld-by-region-by-country-opportunities-and-forecast-2017-2022-by-ald-stages-alcoholic-steatosis-alcoholic-steatohepatitis-ash-5300.html Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global
Global Liver Function Tests Market: Rising Cases of Liver Diseases to be Biggest …
Liver function tests (LFT) are blood tests that are used to assess the state of liver and biliary system. The liver processes and filters the blood as it circulates through the body. It performs many vital functions that include preparing blood clotting proteins, metabolization of nutrients, and detoxification of harmful substances. The cells in the liver contain enzymes that are responsible for carrying out the chemical reactions. When liver cells
Widespread Prevalence of Chronic Liver Ailments Fuels Global Liver Diseases Ther …
Widespread prevalence of liver diseases and disorders, increasing geriatric population, and prevalence of unmet medical needs in the case of liver cancer are the primary factors augmenting the demand for effective liver disease therapeutics. Additionally, emerging economies are focusing on fuel vaccination drives to eradicate chronic ailments, which will also give a boost to the global market for liver disease therapeutics. Compiled with the intent of providing a comprehensive snapshot
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production